Safety and Efficacy of Tyrosine Kinase Inhibitors in Immune Thrombocytopenic Purpura: A Systematic Review of Clinical Trials

Safety and Efficacy of Tyrosine Kinase Inhibitors in Immune Thrombocytopenic Purpura: A Systematic Review of Clinical Trials

Immune thrombocytopenic purpura (ITP) is an acquired antibody or cell-mediated platelet damage or decreased platelet production. Steroids, IV immunoglobulins (IVIG), and Rho-anti-D antibodies are the commonly used initial treatments for ITP. However, many ITP patients either do not respond or do not...

Full description

Bibliographic Details
Main Authors: Muhammad Ashar Ali, Muhammad Yasir Anwar, Wajeeha Aiman, Gurneel Dhanesar, Zainab Omar, Mohammad Hamza, Maha Zafar, Harish Kumar Rengarajan, Michael Maroules
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Journal of Xenobiotics
Subjects:
tyrosine kinase inhibitors
immune thrombocytopenia
Bruton’s tyrosine kinase
splenic tyrosine kinase
clinical trials
Online Access:https://www.mdpi.com/2039-4713/13/1/5

Internet

https://www.mdpi.com/2039-4713/13/1/5

Similar Items